Microbial Metallomics

Uncategorized

Microbiome Medicine

October 1, 2025

Microbiome medicine is an emerging discipline that studies how human-associated microbial communities contribute to health and disease and how they can be measured and intentionally modulated for prevention and therapy. It integrates genomics, metagenomics, metabolomics, and systems biology to uncover causal pathways and to inform microbiome‑targeted interventions (e.g., diet, probiotics, live biotherapeutics, and fecal microbiota transplantation). Metals (e.g., Fe, Zn, Cu, Mn) are central cofactors in microbial metabolism and immunity; thus, microbial metallomics—the study of microbe–metal interactions—provides a mechanistic bridge between environmental/nutritional metal availability and microbiome function, virulence, dysbiosis, and host outcomes.[1][2]

Overview of the Microbiome

The microbiome refers to the collective genomes of the microbes (microbiota) that inhabit body sites (e.g., gut, skin, oral cavity) and their “theatre of activity,” including metabolites and local conditions.[1][2]

Functions of the Microbiome

Microbiota influence digestion, immune development, barrier integrity, xenobiotic metabolism, and neuroimmune signaling relevant to conditions such as metabolic disease, inflammatory bowel disease, asthma, and neurobehavioral disorders.[3][4] Ongoing work continues to define what constitutes a “healthy” microbiome and how it varies across individuals and contexts.[5][6]

Defining the Microbiome

The term “microbiome” dates to 1988 and has since been refined to clearly distinguish it from “microbiota,” while emphasizing ecological function and the One Health context.[4]

Composition and Diversity

Healthy microbiomes are diverse and functionally resilient; their composition is shaped by diet, drugs, environment, and host genetics.[7][5] Although widely cited claims once suggested a ten‑to‑one ratio of microbial to human cells and several pounds of microbial biomass, contemporary estimates are closer to parity and context‑dependent.[8][3]

Microbiome Medicine

Microbiome medicine integrates metagenomics, metabolomics, and causal inference to translate microbiome science into diagnostics and therapeutics.[8] The field underpins precision medicine by linking microbial functions and metabolites to individual risk and treatment response.[9]

Understanding the Human Microbiome

Large consortia and longitudinal cohorts continue to map microbial communities and their functions, enabling stratified interventions and risk prediction.[9]

Therapeutic Applications

Interventions include diet, prebiotics/probiotics, live biotherapeutic products (LBPs), postbiotics, and fecal microbiota transplantation, with expanding clinical evidence and regulatory frameworks.[8][9]

Challenges and Future Perspectives

Key challenges include standardization, causality, durability of effects, safety, and equitable access, all situated within a One Health framework.[8]

Microbial Metallomics

Microbial metallomics investigates how microbes acquire, traffic, utilize, and detoxify metals within biological systems, particularly the gut, and how these processes shape microbial ecology and host physiology.[10]

Importance of Metals in Microbial Function

Transition metals (e.g., Fe, Zn, Mn, Cu) serve as enzyme cofactors and structural elements critical for microbial growth, stress responses, and virulence.[11][12] Both deficiency and excess of essential metals can remodel communities and functions; toxic metals (e.g., Cd, Pb, Hg) perturb metabolism and immunity via the microbiome.[13][14]

Metal Acquisition and Regulation

Microbes deploy siderophores, importers/efflux pumps, and secretion systems (e.g., T6SS) to compete for metals and resist toxicity; hosts counterbalance via “nutritional immunity.”[12][6] Microbial Cu/Zn homeostasis underpins survival, pathogenesis, and antibiotic tolerance.[15] Environmental metal loads and chronic exposure can destabilize microbial interaction networks and reduce ecological resilience.[16][17]

Implications for Health and Disease

Metal dyshomeostasis and toxic exposures are linked to dysbiosis, inflammation, metabolic disease, and neurodevelopmental outcomes via microbe–metal–host signaling axes.[14] Integrating metallomics with microbiome profiles helps explain diet, environment, and exposure effects on host phenotypes and guides risk mitigation.[10][17]

Intersection of Microbiome Medicine and Microbial Metallomics

Role of Metals in Microbiome Function

Metal availability alters microbial gene expression, metabolite production, and interspecies competition, shifting community structure and functional outputs in ways that influence disease trajectories and therapy response.[10][12] Emerging data connect metal exposure and microbiome changes to growth and metabolic outcomes in early life and to specific weight‑gain patterns.[18][15] Systematic reviews corroborate associations between toxic metals and human gut dysbiosis.[19]

Microbial Community Dynamics and Metal Bioavailability

Dietary metals, chelators, and host sequestration mechanisms (e.g., lipocalin‑2, calprotectin) shape metal bioavailability, altering pathogen–commensal competition and microbial network stability.[11] Metallomics provides a framework for measuring these dynamics and designing microbiome‑targeted interventions (MBTIs) that modulate metal niches.[14][20] Conceptual translations of metallomic signatures into clinical decision tools are under active development.[10]

Implications for Disease and Therapeutic Strategies

Microbiome medicine increasingly recognizes metal‑dependent virulence factors and metal‑conditioned ecological states as therapeutic targets. Foundational cohort and review work defines healthy baselines and guides indication‑specific MBTIs; reputable clinical resources help contextualize public interest and patient education.[7][21][22]

Research and Future Directions

Advances in Methodology

High‑resolution mass spectrometry, metalloproteomics, and isotope‑resolved analyses (e.g., infection metallomics) are expanding biomarker discovery and mechanism‑of‑action studies across infectious and inflammatory diseases.[23][20] Ethical frameworks and biobanking standards are being formalized for responsible translation of microbiome science.[5]

Therapeutic Applications

LBPs, next‑generation probiotics, phage/CRISPR approaches, and FMT‑derived strategies are entering clinical trials for GI, immune, metabolic, and neuroimmune indications; public‑facing summaries highlight the promise and limits of “bugs as drugs.”[24][8] Metal dyshomeostasis is increasingly implicated in gut pathology and may be a modifiable axis in disorders such as autism spectrum disorders.[25]

Future Perspectives

Continued standardization, causal modeling, and integrative multi‑omics—including metallomics—are expected to improve patient stratification and guide precision MBTIs. Emerging ingestible devices may sample and deliver therapeutics along the GI tract to operationalize microbiome medicine at the point of need.[8][26][17]

References

  1. Aggarwal N, Kitano S, Puah GRY, Kittelmann S, Hwang IY, Chang MW. Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies. Chem Rev. 2023;123(1):31‑72. https://doi.org/10.1021/acs.chemrev.2c00431.
  2. National Human Genome Research Institute (NHGRI). Microbiome. Genome.gov. https://www.genome.gov/genetics-glossary/Microbiome.
  3. Baylor College of Medicine. The Human Microbiome. https://www.bcm.edu/departments/molecular-virology-and-microbiology/emerging-infections-and-biodefense/microbiome.
  4. Microbiome. Wikipedia. https://en.wikipedia.org/wiki/Microbiome.
  5. Lange L, Sessitsch A, Schloter M, et al. Microbiome ethics, guiding principles for microbiome research, use and knowledge management. Environ Microbiome. 2022;17:50. https://doi.org/10.1186/s40793-022-00444-y.
  6. Metal Metabolism – an overview. ScienceDirect Topics. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/metal-metabolism.
  7. Lloyd‑Price J, Abu‑Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51. https://doi.org/10.1186/s13073-016-0307-y.
  8. Berg G, Rybakova D, Fischer D, et al. Microbiome definition re‑visited: old concepts and new challenges. Microbiome. 2020;8(1):119. https://doi.org/10.1186/s40168-020-00875-0.
  9. Gebrayel P, Nicco C, Al Khodor S, et al. Microbiota medicine: towards clinical revolution. J Transl Med. 2022;20(1):111. https://doi.org/10.1186/s12967-022-03296-9.
  10. Microbial Metallomics. Microbiome Signatures. https://microbiomesignatures.com/definition/microbial-metallomics/.
  11. Egan MS, de Macedo R, Zackular JP. Metals in the gut: microbial strategies to overcome nutritional immunity in the intestinal tract. Metallomics. 2024;16(12):mfae052. https://doi.org/10.1093/mtomcs/mfae052.
  12. Yang X, Yang F, Wong M, et al. Roles of Type VI Secretion System in Transport of Metal Ions. Front Microbiol. 2021;12:756136. https://doi.org/10.3389/fmicb.2021.756136.
  13. Zhu Q, Zhang Y, Chen Y, et al. Toxic and essential metals: metabolic interactions with the gut microbiota and health implications. Front Nutr. 2024;11:1448388. https://doi.org/10.3389/fnut.2024.1448388.
  14. Zhu Q, Zhang Y, Chen Y, et al. Toxic and essential metals: metabolic interactions with the gut microbiota and health implications. Front Nutr. 2024;11:1448388. https://doi.org/10.3389/fnut.2024.1448388.
  15. Sullivan MJ, Terán I, Goh KGK, Ulett GC. Resisting death by metal: metabolism and Cu/Zn homeostasis in bacteria. Emerg Top Life Sci. 2024;8(1):45‑56. https://doi.org/10.1042/ETLS20230115.
  16. Sun S, Wu P, Wang G, Kong X. Heavy metal pollution decreases the stability of microbial co‑occurrence networks in the rhizosphere of native plants. Front Environ Sci. 2022;10:979922. https://doi.org/10.3389/fenvs.2022.979922.
  17. Giambò F, Teodoro M, Costa C, Fenga C. Influence of toxic metal exposure on the gut microbiota (Review). World Acad Sci J. 2021;3:19. https://doi.org/10.3892/wasj.2021.90.
  18. Peng Y, Pan X, et al. The effects of metals and gut microbiota on weight gain patterns in children admitted to the neonatal intensive care unit: A prospective cohort study. J Hazard Mater Adv. 2025;19:100839. https://doi.org/10.1016/j.hazadv.2025.100839.
  19. Rezazadegan M, Forootani B, Hoveyda Y, Rezazadegan N, Amani R. Major heavy metals and human gut microbiota composition: a systematic review with nutritional approach. J Health Popul Nutr. 2025;44:21. https://doi.org/10.1186/s41043-025-00750-4.
  20. What Is Metallomics? Creative Proteomics Blog. https://www.creative-proteomics.com/blog/what-is-metallomics.htm.
  21. What Is Your Gut Microbiome? Cleveland Clinic. https://my.clevelandclinic.org/health/body/25201-gut-microbiome.
  22. Metallomic Signatures. Microbiome Signatures. https://microbiomesignatures.com/definition/metallomic-signatures/.
  23. Patil RH, Luptáková D, Havlíček V. Infection metallomics for critical care in the post‑COVID era. Mass Spectrom Rev. 2023;42(4):1221‑1243. https://doi.org/10.1002/mas.21755.
  24. Microbiome Medicine: Scientists Harness the Body’s “Bugs” to Treat Asthma, MS and More. UCSF News. https://www.ucsf.edu/news/2021/06/420911/microbiome-medicine-scientists-harness-bodys-bugs-treat-asthma-ms-and-more.
  25. O’Grady K, Grabrucker AM. Metal Dyshomeostasis as a Driver of Gut Pathology in Autism Spectrum Disorders. J Neurochem. 2025;169(3):e70041. https://doi.org/10.1111/jnc.70041.
  26. Gut in a Capsule – The Microbiome as Medicine. University of Pittsburgh, Swanson School of Engineering. https://news.engineering.pitt.edu/gut-in-a-capsule-the-microbiome-as-medicine/.